The effect of COVID-19 on micro RNA and therefore gene expression
Keywords:
SARS-CoV-2, human ACE2, vaccination, micro RNAAbstract
After the scourge of the coronavirus invaded almost all of the world, they were infected with this epidemic, and therefore this has caused changes and variations within the corridors of living cells, which have transgressed to some organs and even systems, which were not spared most of the vital pathways and the natural interdependence that regulates natural activities. Some studies also indicate that the family of The coronavirus reached its claws to the skin of genes and gene expression, thus opening the doors of genetics and molecular bio to study and investigate everything that this nano creature might affect. Which has been used by many vaccines that did not intercede to withdraw terror from those who hear the term Covid 19. This study sheds light on the effect of Covid 19 on the microRNA, which shows the extent of the disease's impact on this indicator that regulates gene expression, which consequently causes an imbalance in gene expression.we will review research that examined the relationship between covid 19 and its effect on the micro RNA and findings of it.
Downloads
References
Alam, Shahriar Tanvir et al. 2021. “Challenges to COVID-19 Vaccine Supply Chain: Implications for Sustainable Development Goals.” International Journal of Production Economics 239(June): 108193. https://doi.org/10.1016/j.ijpe.2021.108193. DOI: https://doi.org/10.1016/j.ijpe.2021.108193
Barnes, Stuart J. 2020. “Information Management Research and Practice in the Post-COVID-19 World.” International Journal of Information Management 55(June): 102175. https://doi.org/10.1016/j.ijinfomgt.2020.102175. DOI: https://doi.org/10.1016/j.ijinfomgt.2020.102175
Dror, Amiel A. et al. 2020. “Vaccine Hesitancy: The next Challenge in the Fight against COVID-19.” European Journal of Epidemiology 35(8): 775–79. https://doi.org/10.1007/s10654-020-00671-y. DOI: https://doi.org/10.1007/s10654-020-00671-y
Funk, Colin D., Craig Laferrière, and Ali Ardakani. 2021. “Target Product Profile Analysis of Covid-19 Vaccines in Phase Iii Clinical Trials and beyond: An Early 2021 Perspective.” Viruses 13(3): 1–19. DOI: https://doi.org/10.3390/v13030418
Graham, By Barney S. 2020. “Rapid COVID-19 Vaccine Development Availability Includes the Avoidance of Safety Pitfalls.” Science 368(6494): 945–46. https://science.sciencemag.org/content/368/6494/945. DOI: https://doi.org/10.1126/science.abb8923
Jansson, Martin D., and Anders H. Lund. 2012. “MicroRNA and Cancer.” Molecular Oncology 6(6): 590–610. http://dx.doi.org/10.1016/j.molonc.2012.09.006. DOI: https://doi.org/10.1016/j.molonc.2012.09.006
Kim, V. Narry, and Jin Wu Nam. 2006. “Genomics of MicroRNA.” Trends in Genetics 22(3): 165–73. DOI: https://doi.org/10.1016/j.tig.2006.01.003
Knoll, Maria Deloria, and Chizoba Wonodi. 2021. “Oxford–AstraZeneca COVID-19 Vaccine Efficacy.” The Lancet 397(10269): 72–74. DOI: https://doi.org/10.1016/S0140-6736(20)32623-4
Li, Caixia, Xiao Hu, Leilei Li, and Jin hui Li. 2020. “Differential MicroRNA Expression in the Peripheral Blood from Human Patients with COVID-19.” Journal of Clinical Laboratory Analysis 34(10): 3334–40. DOI: https://doi.org/10.1002/jcla.23590
Mittal, Anshumali et al. 2020. “COVID-19 Pandemic: Insights into Structure, Function, and HACE2 Receptor Recognition by SARS-CoV-2.” PLoS pathogens 16(8): e1008762. http://dx.doi.org/10.1371/journal.ppat.1008762. DOI: https://doi.org/10.1371/journal.ppat.1008762
Pandey, Satish Chandra et al. 2020. “Vaccination Strategies to Combat Novel Corona Virus SARS-CoV-2.” Life Sciences 256(April): 117956. https://doi.org/10.1016/j.lfs.2020.117956. DOI: https://doi.org/10.1016/j.lfs.2020.117956
Sanders, James M., Marguerite L. Monogue, Tomasz Z. Jodlowski, and James B. Cutrell. 2020. “Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.” JAMA - Journal of the American Medical Association 323(18): 1824–36. DOI: https://doi.org/10.1001/jama.2020.6019
Shang, Jian et al. 2020. “Cell Entry Mechanisms of SARS-CoV-2.” Proceedings of the National Academy of Sciences of the United States of America 117(21). DOI: https://doi.org/10.1073/pnas.2003138117
Wang, Qihui et al. 2020. “Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.” Cell 181(4): 894-904.e9. DOI: https://doi.org/10.1016/j.cell.2020.03.045
Xu, Bo et al. 2020. “Epidemiological Data from the COVID-19 Outbreak, Real-Time Case Information.” Scientific Data 7(1): 1–6. DOI: https://doi.org/10.1038/s41597-020-0448-0
Zhu, Feng Cai et al. 2020. “Safety, Tolerability, and Immunogenicity of a Recombinant Adenovirus Type-5 Vectored COVID-19 Vaccine: A Dose-Escalation, Open-Label, Non-Randomised, First-in-Human Trial.” The Lancet 395(10240): 1845–54. http://dx.doi.org/10.1016/S0140-6736(20)31208-3. DOI: https://doi.org/10.1016/S0140-6736(20)31208-3
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
